Pharmaceutical Technology on MSN
Seaport and Hemab target $180m IPOs as biotech listings accumulate
Seaport will use the funds for its neuropsychiatric drug pipeline, while Hemab will focus on bleeding disorder medicines.
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform ...
Hosted on MSN
Biotech Ingredients Are Beauty’s Next Big Thing—Here’s How They’re Changing Skincare as We Know It
When it comes to beauty formulations that are inclusive of people and planet, finding a middle ground is not always easy. Natural ingredients often rely on farming practices that often require a lot ...
Pharmaceutical Technology on MSN
UK biotech could be bound for recovery, BIA report reveals
With an uptick and increasingly even spread of capital across the space, the BIA’s Martin Turner is optimistic for British biotech’s future.
Debut Biotech, a company innovating new molecules, is partnering with Image Skincare to launch a new beauty product, CNBC has learned. The San Diego-based company uses biotechnology and artificial ...
Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 10 best biotech stocks with highest upside potential. On April 6, Denali ...
Trinity Biotech plc announced a significant step in its transformation plan by appointing Barclays Capital Inc. as its exclusive financial advisor. The company is shifting its focus to developing its ...
The American Seed Trade Association will be the lead advocate for crop biotechnology now that the Biotechnology Innovation Organization has eliminated its agriculture and environment section. ASTA was ...
Bernhard running samples at the DARO lab at the BioTech Connector on the Nebraska Innovation Campus. Photo provided by DARO. DARO, a biotech startup in Lincoln centered around early disease detection ...
A Frederick biotech company will unveil a new technology allowing cellular-level observation of tumors at a conference in Philadelphia next week. Nanocrine, based in the headquarters for the Frederick ...
MARTINSRIED, Germany--(BUSINESS WIRE)--SIRION Biotech GmbH announced today that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST™ for use in their CAR-T cell products. CAR-T cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results